Breast milk dominant phyla and probiotic bacteria in the obese lactating women compared with normal weights.

The main purpose was to determine the abundance of dominant phyla, Bifidobacterium spp., and Lactobacillus in breast milk of obese mothers versus normal-weights in fourth month of lactation in Iranian population. Sixty health women at the fourth month of breastfeeding, aged 18-40 years, were included and categorized based on body mass index (BMI) to the obese (BMI ≥ 30 kg/m2) and normal-weights (18.5 ≤ BMI ≤ 24.9). Bacterial DNA was extracted and qPCR of the 16S region was performed after human milk donation in a sterile condition. A multiple linear mixed model was used to determine the effective factors on the phyla population. Bifidobacterium spp. was significantly higher in milk of normal-weight group than the obese. The current weight showed a significant effect on the Actinobacteria abundance in milk. The Bacteroidetes and Firmicutes were significantly lower in mother's milk with cesarean section (p = 0.04). Pre-pregnancy obesity decreased the Firmicutes and Lactobacillus abundance in maternal milk (p = 0.04 and p = 0.01). The Actinobacteria and Bifidobacterium spp. showed a significant effect on infant's height (p = 0.008 and p = 0.04). The maternal current and pre-pregnancy weight showed an important effect on abundance of Actinobacteria and Bifidobacterium spp., as the good phyla and genus in milk which are associated with the infant's height.

Green synthesis and characterization of α-Mn2O3 nanoparticles for antibacterial activity and efficient visible-light photocatalysis.

In this study, green synthesis, characterizations, photocatalytic performance, and antibacterial applications of α-Mn2O3 nanoparticles are reported. The synthesized nanoparticles were characterized by Fourier transform infrared spectroscopy (FT-IR), powder X-ray diffraction (XRD), transmission electron microscope (TEM), Scanning electron microscopy (SEM), energy dispersive X-ray analysis (EDX), Brunauer Emmett Teller (BET), Electrochemical Impedance Spectroscopy (EIS), Photoluminescence (PL), and Differential reflectance spectroscopy (DRS) analysis. The investigation verified that the α-Mn2O3 nanoparticles possessed a cubic structure, with a crystallite size of 23 nm. The SEM and TEM techniques were used to study the nanoscale morphology of α- Mn2O3 nanoparticles, which were found to be spherical with a size of 30 nm. Moreover, the surface area was obtained as 149.9 m2 g-1 utilizing BET analysis, and the band gap was determined to be 1.98 eV by DRS analysis. The photocatalysis performance of the α-Mn2O3 NPs was evaluated for degrading Eriochrome Black T (EBT) dye under visible light and degradation efficiency was 96% in 90 min. The photodegradation mechanism of EBT dye was clarified with the use of radical scavenger agents, and the degradation pathway was confirmed through Liquid Chromatography-Mass Spectrometry (LC-MS) analysis. Additionally, the produced nanoparticles could be extracted from the solution and continued to exhibit photocatalysis even after five repeated runs under the same optimal conditions. Also, the antibacterial activity of green synthesized α-Mn2O3 nanoparticles was investigated by using the broth microdilution method towards Enterococcus faecalis ATCC 29212 (Gram-positive), Staphylococcus aureus ATCC 29213 (Gram-positive), Salmonella typhimurium ATCC 14028 (Gram-negative), Klebsiella pneumoniae ATCC 7881 (Gram-negative), Escherichia coli ATCC 25922 (Gram-negative), Proteus mirabilis ATCC 7002 (Gram-negative), and Pseudomonas aeruginosa ATCC 27853 (Gram-negative) bacterial strains.

Application of Next-generation Sequencing in Clinical Molecular Diagnostics

ABSTRACT Next-generation sequencing (NGS) is the catch all terms that used to explain several different modern sequencing technologies which let us to sequence nucleic acids much more rapidly and cheaply than the formerly used Sanger sequencing, and as such have revolutionized the study of molecular biology and genomics with excellent resolution and accuracy. Over the past years, many academic companies and institutions have continued technological advances to expand NGS applications from research to the clinic. In this review, the performance and technical features of current NGS platforms were described. Furthermore, advances in the applying of NGS technologies towards the progress of clinical molecular diagnostics were emphasized. General advantages and disadvantages of each sequencing system are summarized and compared to guide the selection of NGS platforms for specific research aims.